Table 1 Baseline characteristics of the patients with ATTRwt amyloidosis included in the study. n = 61.
From: Days alive and out of hospital in patients with wild type transthyretin amyloidosis: cohort study
Baseline characteristics | n = 61 |
|---|---|
Median age, years (IQR) | 83 (80–87) |
Male, n (%) | 54 (89) |
Atrial fibrillationhistory, n (%) | 32 (52) |
Chronic renal failure, n (%) | 6 (10) |
CHF, n (%) | 44 (72) |
Previous hospitalizations due to CHF, n (%) | 24 (39) |
Median charlson comorbidity index score*, (IQR) | 5 (4–7) |
Median proBNP Level in pg/ml, (IQR) | 3158 (2147–7174) |
Median creatinine level in mg/dL, (IQR) | 1.27 (1.08–1.44) |
Median eGFR, mL/min/1.73m2 (IQR) | 53 (45–66) |
Median ejection fraction, (IQR) | 52 (45–61) |
NAC staging, n (%) | |
Stage I | 23 (38) |
Stage II | 26 (42) |
Stage III | 12 (20) |
